CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,226,243
+155.6%
324,403
+353.0%
0.00%
Q2 2023$479,794
+355.8%
71,611
+342.9%
0.00%
Q1 2023$105,267
-23.7%
16,1700.0%0.00%
Q4 2022$137,930
-69.5%
16,170
-84.8%
0.00%
Q2 2022$452,000
-12.7%
106,414
-27.8%
0.00%
Q1 2022$518,000
-47.8%
147,375
-1.1%
0.00%
Q4 2021$992,000
-28.6%
148,943
+7.1%
0.00%
Q3 2021$1,389,000
-47.6%
139,105
+62.1%
0.00%
-100.0%
Q2 2021$2,651,000
-28.0%
85,804
+1.6%
0.00%0.0%
Q1 2021$3,683,00084,4130.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 8,740,887$87,234,0000.96%
Boxer Capital, LLC 1,675,377$16,720,0000.58%
EcoR1 Capital, LLC 1,184,710$11,823,0000.41%
Nantahala Capital Management 1,226,631$12,242,0000.39%
5AM Venture Management, LLC 169,748$1,694,0000.34%
COMMODORE CAPITAL LP 97,143$969,0000.26%
RA Capital Management 1,742,186$17,387,0000.24%
HighVista Strategies LLC 22,434$224,0000.15%
Rhenman & Partners Asset Management AB 150,000$1,497,0000.10%
Woodline Partners LP 425,261$4,244,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders